Bidiphar completes research on cancer treatment technologies

Binh Dinh Pharmaceutical and Medical Equipments Joint Stock Company (Bidiphar) has completed the state-level science and technology project on technologies for manufacturing cancer treatment medicine after two years of study.

The company also improved the process of manufacturing technology of six elements of injection and 10 type of  lyophilized injections to treat cancer in industrial scale.

Bidiphar has commercialized 400,000 potions, saving over VND 20 billion for patients beacuse its price is 20-30 percent cheaper than imported price.

The project was developed from April 2014 with total cost of VND 243.9 billion and its period of up to 60 months.

Mai Hoang

(0)
Other news